409 related articles for article (PubMed ID: 28578681)
1. Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.
Schmitz K; Brunkhorst R; de Bruin N; Mayer CA; Häussler A; Ferreiros N; Schiffmann S; Parnham MJ; Tunaru S; Chun J; Offermanns S; Foerch C; Scholich K; Vogt J; Wicker S; Lötsch J; Geisslinger G; Tegeder I
Acta Neuropathol Commun; 2017 Jun; 5(1):42. PubMed ID: 28578681
[TBL] [Abstract][Full Text] [Related]
2. Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis.
Fransson J; Gómez-Conde AI; Romero-Imbroda J; Fernández O; Leyva L; de Fonseca FR; Chun J; Louapre C; Van-Evercooren AB; Zujovic V; Estivill-Torrús G; García-Díaz B
Mol Neurobiol; 2021 Feb; 58(2):470-482. PubMed ID: 32974731
[TBL] [Abstract][Full Text] [Related]
3. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB
J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lysophosphatidic acid receptor 1-3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stress.
Choi JH; Oh J; Lee MJ; Bae H; Ko SG; Nah SY; Cho IH
J Neuroinflammation; 2021 Oct; 18(1):240. PubMed ID: 34666785
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis.
Poon MM; Lorrain KI; Stebbins KJ; Edu GC; Broadhead AR; Lorenzana AO; Paulson BE; Baccei CS; Roppe JR; Schrader TO; Valdez LJ; Xiong Y; Chen AC; Lorrain DS
Sci Rep; 2024 May; 14(1):10573. PubMed ID: 38719983
[TBL] [Abstract][Full Text] [Related]
6. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum [Met
Ludwig MD; Zagon IS; McLaughlin PJ
Brain Res Bull; 2017 Sep; 134():1-9. PubMed ID: 28647454
[TBL] [Abstract][Full Text] [Related]
8. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.
Uyttenhove C; Gaignage M; Donckers D; Nasr Z; Cheou P; van Snick J; D'Auria L; van Pesch V
Eur J Immunol; 2018 Nov; 48(11):1883-1891. PubMed ID: 30216414
[TBL] [Abstract][Full Text] [Related]
11. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
13. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
[TBL] [Abstract][Full Text] [Related]
14. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
[TBL] [Abstract][Full Text] [Related]
15. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.
Fazio F; Notartomaso S; Aronica E; Storto M; Battaglia G; Vieira E; Gatti S; Bruno V; Biagioni F; Gradini R; Nicoletti F; Di Marco R
Neuropharmacology; 2008 Sep; 55(4):491-9. PubMed ID: 18619983
[TBL] [Abstract][Full Text] [Related]
16. The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway.
Luo J; Chen R; Zeng S; Yu J; Jiang G; Wang L; Qin X
Biochem Biophys Res Commun; 2017 Aug; 490(3):927-932. PubMed ID: 28655617
[TBL] [Abstract][Full Text] [Related]
17. Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.
Choi BY; Jang BG; Kim JH; Seo JN; Wu G; Sohn M; Chung TN; Suh SW
Neurobiol Dis; 2013 Jun; 54():382-91. PubMed ID: 23360710
[TBL] [Abstract][Full Text] [Related]
18. The Anti-Inflammatory Effects of Oral-Formulated Tacrolimus in Mice with Experimental Autoimmune Encephalomyelitis.
Kim MJ; Sung JJ; Kim SH; Kim JM; Jeon GS; Mun SK; Ahn SW
J Korean Med Sci; 2017 Sep; 32(9):1502-1507. PubMed ID: 28776347
[TBL] [Abstract][Full Text] [Related]
19. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
Garay L; Gonzalez Deniselle MC; Meyer M; Costa JJ; Lima A; Roig P; De nicola AF
Brain Res; 2009 Aug; 1283():177-85. PubMed ID: 19497309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
